The Research Group in Iron Metabolism: Regulation and Diseases is a senior interdisciplinary group with extensive experience in translational medicine in the field of iron metabolism and in the study of hereditary haematological diseases.
The purpose of the group is to increase knowledge of iron metabolism, its regulation and associated diseases, and to promote the diagnosis of hereditary haematological diseases. To this end, the innovative SMEBLOODGENETICS SL was created in November 2016. The group has also contributed to the implementation of telemedicine tools to facilitate the diagnosis and management of patients with inherited haematological diseases such as congenital dyserythropoietic anaemia (CODYSAN) and the diagnosis and management of patients with hyperferritinemia (HIGHFERRITIN). We have also contributed to the publication of several clinical guidelines.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.